LeMaitre Vascular Inc (LMAT) Analysts See $0.17 EPS

July 18, 2017 - By Darrin Black

 LeMaitre Vascular Inc (LMAT) Analysts See $0.17 EPS
Investors sentiment decreased to 1.12 in 2016 Q4. Its down 0.44, from 1.56 in 2016Q3. It is negative, as 11 investors sold LeMaitre Vascular Inc shares while 39 reduced holdings. 18 funds opened positions while 38 raised stakes. 10.81 million shares or 0.20% more from 10.78 million shares in 2016Q3 were reported.
Comml Bank Of New York Mellon accumulated 87,144 shares. Northern Trust, a Illinois-based fund reported 200,774 shares. Goldman Sachs Grp reported 0% stake. Creative Planning invested in 0% or 200 shares. Sei Invests owns 3,327 shares for 0% of their portfolio. Columbia Wanger Asset Mgmt Ltd Co has invested 0.32% in LeMaitre Vascular Inc (NASDAQ:LMAT). Prudential invested in 95,310 shares or 0% of the stock. Vanguard Inc has 619,883 shares for 0% of their portfolio. American holds 0% or 7,765 shares in its portfolio. Manufacturers Life Insur The owns 9,217 shares for 0% of their portfolio. Blackrock Japan Commerce Ltd accumulated 2,327 shares. Ameriprise Fincl reported 132,322 shares stake. Aqr Capital Mgmt Ltd owns 0.01% invested in LeMaitre Vascular Inc (NASDAQ:LMAT) for 162,363 shares. Numeric Investors Lc reported 26,300 shares. 65,307 are owned by Martingale Asset Mgmt Limited Partnership.

Since February 27, 2017, it had 0 insider purchases, and 9 insider sales for $8.92 million activity. $2.83 million worth of LeMaitre Vascular Inc (NASDAQ:LMAT) was sold by LeMaitre George W. Wijas Michael T also sold $73,717 worth of LeMaitre Vascular Inc (NASDAQ:LMAT) on Thursday, June 1. Shares for $477,822 were sold by Kamke Trent G on Wednesday, May 24.

Wall Street await LeMaitre Vascular Inc (NASDAQ:LMAT) to release earnings on July, 26. Analysts forecast EPS of $0.17, up exactly $0.03 or 21.43 % from 2014’s $0.14 EPS. The expected LMAT’s profit could reach $3.21 million giving the stock 43.50 P/E in the case that $0.17 earnings per share is reported. After posting $0.16 EPS for the previous quarter, LeMaitre Vascular Inc’s analysts now forecast 6.25 % EPS growth. The stock increased 1.51% or $0.44 during the last trading session, reaching $29.58. About 155,790 shares traded. LeMaitre Vascular Inc (NASDAQ:LMAT) has risen 101.07% since July 18, 2016 and is uptrending. It has outperformed by 84.37% the S&P500.

LeMaitre Vascular Inc (NASDAQ:LMAT) Ratings Coverage

Among 11 analysts covering LeMaitre Vascular (NASDAQ:LMAT), 7 have Buy rating, 0 Sell and 4 Hold. Therefore 64% are positive. LeMaitre Vascular had 26 analyst reports since July 29, 2015 according to SRatingsIntel. As per Thursday, September 22, the company rating was downgraded by Sidoti. The firm earned “Outperform” rating on Wednesday, October 28 by Barrington Research. TH Capital maintained the stock with “Buy” rating in Monday, December 7 report. The stock has “Buy” rating by Stifel Nicolaus on Friday, December 4. The stock of LeMaitre Vascular Inc (NASDAQ:LMAT) earned “Hold” rating by Benchmark on Monday, July 10. The stock of LeMaitre Vascular Inc (NASDAQ:LMAT) has “Buy” rating given on Tuesday, May 3 by Roth Capital. The firm earned “Neutral” rating on Wednesday, January 20 by Sidoti. The rating was maintained by Canaccord Genuity on Tuesday, May 3 with “Buy”. The stock of LeMaitre Vascular Inc (NASDAQ:LMAT) earned “Mkt Perform” rating by Barrington Research on Thursday, September 10. Benchmark maintained LeMaitre Vascular Inc (NASDAQ:LMAT) on Wednesday, July 29 with “Buy” rating.

LeMaitre Vascular, Inc. is a provider of medical devices for the treatment of peripheral vascular disease. The company has market cap of $558.10 million. The Firm develops, makes and markets medical devices and implants used primarily in the field of vascular surgery. It has a 49.29 P/E ratio. It is engaged in the design, marketing, sales and technical support of medical devices and implants for the treatment of peripheral vascular disease industry segment.

More notable recent LeMaitre Vascular Inc (NASDAQ:LMAT) news were published by: Globenewswire.com which released: “LeMaitre Vascular Will Announce Third Quarter 2016 Earnings Results on October …” on October 18, 2016, also Nasdaq.com with their article: “BUZZ-US STOCKS ON THE MOVE- Freeport-McMoRan, Abercrombie, Hawaii Telecom …” published on July 10, 2017, Globenewswire.com published: “LeMaitre Vascular Acquires Restore Flow Allografts” on November 10, 2016. More interesting news about LeMaitre Vascular Inc (NASDAQ:LMAT) were released by: Seekingalpha.com and their article: “LeMaitre Vascular’s (LMAT) CEO George LeMaitre on Q1 2017 Results – Earnings …” published on April 27, 2017 as well as Zacks.com‘s news article titled: “Is LeMaitre Vascular (LMAT) Great Growth Stock? November 01, 2016” with publication date: September 20, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.